India Urges Reluctant MNCs To Launch New Drugs In Country
This article was originally published in PharmAsia News
Executive Summary
The Indian government is urging multinational pharmaceutical companies to launch their new drugs in India, most of them for the first time since 1995. Some MNCs stopped marketing their drugs in India because of a fear that local generics makers would make illegal copies of MNC drugs. Some drug industry insiders believe India would have to improve its patent laws before MNCs could be enticed to launch their new drugs in the country. They point to Roche and Pfizer, who have lawsuits pending in court, claiming infringement of their patents by generic companies copying recently launched products. (Click here for more